Cargando…
A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets
Immunoglobulin A (IgA) of sows is critically important for assessing piglets’ protective capacity against porcine epidemic diarrhea virus (PEDV). Here, we report a therapeutic chimeric anti-PEDV IgG/IgA expressed by Chinese hamster ovary (CHO) cells for oral treatment of PED. The chimeric anti-PEDV...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574063/ https://www.ncbi.nlm.nih.gov/pubmed/36262323 http://dx.doi.org/10.3389/fmicb.2022.1018748 |
_version_ | 1784811020523405312 |
---|---|
author | Xiao, Yan Zhang, Yunjing Wang, Zhiyan Zhao, Wenyin Xu, Xin Chen, Xiao Tan, Feifei Sun, Zhe Huang, Baicheng Tian, Kegong |
author_facet | Xiao, Yan Zhang, Yunjing Wang, Zhiyan Zhao, Wenyin Xu, Xin Chen, Xiao Tan, Feifei Sun, Zhe Huang, Baicheng Tian, Kegong |
author_sort | Xiao, Yan |
collection | PubMed |
description | Immunoglobulin A (IgA) of sows is critically important for assessing piglets’ protective capacity against porcine epidemic diarrhea virus (PEDV). Here, we report a therapeutic chimeric anti-PEDV IgG/IgA expressed by Chinese hamster ovary (CHO) cells for oral treatment of PED. The chimeric anti-PEDV IgG/IgA was produced by the CHO cell lines, in which the heavy chain was constructed by combining the VH, Cγ1 and hinge regions of PEDV IgG mAb 8A3, and the Cα2 and Cα3 domains of a Mus musculus immunoglobulin alpha chain. The chimeric anti-PEDV IgG/IgA could neutralize the strains of CV777 (G1), P014 (G2) and HN1303 (G2) in vitro effectively, showing broad-spectrum neutralization activity. The in vivo challenge experiments demonstrated that chimeric anti-PEDV IgG/IgA (9C4) produced in the CHO cell supernatant could alleviate clinical diarrhea symptoms of the PEDV infection in piglets. In general, our study showed that chimeric anti-PEDV IgG/IgA produced from CHO cell line supernatants effectively alleviates PEDV infection in piglets, which also gives the foundation for the construction of fully functional secretory IgA by the J chain introduction to maximize the antibody therapeutic effect. |
format | Online Article Text |
id | pubmed-9574063 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95740632022-10-18 A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets Xiao, Yan Zhang, Yunjing Wang, Zhiyan Zhao, Wenyin Xu, Xin Chen, Xiao Tan, Feifei Sun, Zhe Huang, Baicheng Tian, Kegong Front Microbiol Microbiology Immunoglobulin A (IgA) of sows is critically important for assessing piglets’ protective capacity against porcine epidemic diarrhea virus (PEDV). Here, we report a therapeutic chimeric anti-PEDV IgG/IgA expressed by Chinese hamster ovary (CHO) cells for oral treatment of PED. The chimeric anti-PEDV IgG/IgA was produced by the CHO cell lines, in which the heavy chain was constructed by combining the VH, Cγ1 and hinge regions of PEDV IgG mAb 8A3, and the Cα2 and Cα3 domains of a Mus musculus immunoglobulin alpha chain. The chimeric anti-PEDV IgG/IgA could neutralize the strains of CV777 (G1), P014 (G2) and HN1303 (G2) in vitro effectively, showing broad-spectrum neutralization activity. The in vivo challenge experiments demonstrated that chimeric anti-PEDV IgG/IgA (9C4) produced in the CHO cell supernatant could alleviate clinical diarrhea symptoms of the PEDV infection in piglets. In general, our study showed that chimeric anti-PEDV IgG/IgA produced from CHO cell line supernatants effectively alleviates PEDV infection in piglets, which also gives the foundation for the construction of fully functional secretory IgA by the J chain introduction to maximize the antibody therapeutic effect. Frontiers Media S.A. 2022-10-03 /pmc/articles/PMC9574063/ /pubmed/36262323 http://dx.doi.org/10.3389/fmicb.2022.1018748 Text en Copyright © 2022 Xiao, Zhang, Wang, Zhao, Xu, Chen, Tan, Sun, Huang and Tian. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Xiao, Yan Zhang, Yunjing Wang, Zhiyan Zhao, Wenyin Xu, Xin Chen, Xiao Tan, Feifei Sun, Zhe Huang, Baicheng Tian, Kegong A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets |
title | A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets |
title_full | A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets |
title_fullStr | A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets |
title_full_unstemmed | A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets |
title_short | A therapeutic chimeric IgG/IgA expressed by CHO cells for oral treatment of PED in piglets |
title_sort | therapeutic chimeric igg/iga expressed by cho cells for oral treatment of ped in piglets |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574063/ https://www.ncbi.nlm.nih.gov/pubmed/36262323 http://dx.doi.org/10.3389/fmicb.2022.1018748 |
work_keys_str_mv | AT xiaoyan atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT zhangyunjing atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT wangzhiyan atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT zhaowenyin atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT xuxin atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT chenxiao atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT tanfeifei atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT sunzhe atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT huangbaicheng atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT tiankegong atherapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT xiaoyan therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT zhangyunjing therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT wangzhiyan therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT zhaowenyin therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT xuxin therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT chenxiao therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT tanfeifei therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT sunzhe therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT huangbaicheng therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets AT tiankegong therapeuticchimericiggigaexpressedbychocellsfororaltreatmentofpedinpiglets |